Latest 10-Q quarterly reports

Outlook Therapeutics announces FDA approval for LYTENAVA, but faces ongoing financial challenges and substantial doubt regarding its ability to continue as a going concern.

Columbus Circle Capital Corp III, a SPAC, has successfully closed its initial public offering, raising $230 million and placing the proceeds in a trust account while it seeks a business combination.

T3 Defense Inc. filed its Q2 2026 10-Q, detailing significant revenue generation for the first time, but also reporting substantial net losses and ongoing liquidity challenges, while navigating strategic acquisitions and efforts to regain Nasdaq listing compliance.

Polar Power Inc. (POLA) reported a substantial revenue decrease and a widening net loss for Q2 2026, highlighting ongoing financial and operational challenges including component shortages and debt covenant non-compliance.

IRIDEX Corporation's Q2 2026 Form 10-Q filing reveals a 7.4% decrease in quarterly revenue and a widening net loss, alongside persistent macroeconomic challenges and internal governance tensions.

Boost Run Inc. has filed an amendment to its Q1 2026 Form 10-Q, detailing a net loss of $4.12 million and highlighting ongoing material weaknesses in internal controls.

CirTran Corporation reported a significant increase in net sales for the second quarter of 2026, driven by higher demand for vapor products, but faces substantial doubt regarding its ability to continue as a going concern.

Cosmos Health Inc. reported increased revenue for the six months ended June 30, 2026, but also a significant net loss and substantial doubt about its ability to continue as a going concern.

Inno Holdings Inc. reported a significant increase in revenue for the third quarter of 2026, driven by its electronic products trading business, but continued to incur substantial operating losses.

ConnectOne Bancorp, Inc. has filed an amendment to its Form 10-Q for the period ended June 30, 2026, to correct an error in the reported number of outstanding common shares.

Greenwave Technology Solutions reported a significant increase in revenue for the second quarter of 2026, but continues to face substantial doubt regarding its ability to continue as a going concern.

OMNIQ Corp. filed its Q2 2026 10-Q, revealing a revenue decrease, a substantial rise in operating expenses, and a widening net loss, alongside a persistent working capital deficit.

Sypris Solutions, Inc. reported a net loss of $3.11 million for the three months ended July 5, 2026, a significant increase from the prior year, alongside a 3.5% decrease in net revenue.

Azio AI Holdings, Inc. filed its Q2 2026 Form 10-Q, detailing significant net losses, a substantial increase in liabilities, and ongoing concerns about its ability to continue as a going concern, despite strategic acquisitions.

Midera Food Processing's Q2 results show increased net sales driven by acquisitions and international growth, alongside the successful completion of its spin-off from Middleby.

Healthy Choice Wellness Corp. files an amendment to its Q2 2026 10-Q report to correct specific notes, while addressing ongoing going concern risks and recent financing activities.

Crown PropTech Acquisitions reports continued operational losses and extends its business combination deadline to March 11, 2027, while awaiting SEC effectiveness for its merger with Mkango Rare Earths.

ClearThink 1 Acquisition Corp. reports on its financial condition and operational progress for the quarter ended June 30, 2026, highlighting its status as a SPAC and its ongoing efforts to identify and complete a business combination.

Greenland Mines Ltd. (GRML) filed its Q2 2026 Form 10-Q, detailing a strategic shift towards mining with the acquisition of Greenland Mines Corp., while continuing biotech R&D, reporting increased operating expenses and net losses.

NexMetals Mining Corp. reports significant progress in mineral resource estimates for its Botswana projects, but faces substantial doubt regarding its ability to continue as a going concern.

ENvue Medical, Inc. reported a significant decrease in revenue for the second quarter of 2026, alongside an increase in net loss, while also detailing ongoing efforts to secure financing and manage operational challenges.

Constellation Acquisition Corp I's Q2 2026 10-Q filing highlights significant net losses and liquidity challenges, while detailing progress on its proposed business combination with HiTech Minerals Inc.

DocGo Inc. reported a net loss of $18.0 million for Q2 2026, with revenues down 8.7% year-over-year, primarily due to the wind-down of migrant-related services.

Twelve Seas Investment Company III (TWLV) files its Q2 2026 10-Q, reporting income from trust account investments and detailing ongoing efforts to identify and complete a business combination, while acknowledging going concern risks.

Copley Acquisition Corp's Q2 2026 filing reveals net income driven by trust account interest, while highlighting the critical need to finalize its business combination with Ignite Proteomics.

Mitesco, Inc. reported substantial net losses and a critical going concern warning in its Q2 2026 10-Q filing, while detailing new data center and AI software initiatives.

Charlie's Holdings, Inc. Q2 2026 report shows a significant revenue increase driven by nicotine and alternative alkaloid products, but also reveals growing operational losses and ongoing regulatory battles with the FDA.

BT Brands Inc. reported a net loss for the 26-week period ended June 28, 2026, despite a significant unrealized gain on marketable securities and improved operational efficiencies, while also disclosing the termination of its proposed merger with Aero Velocity.

Baltic International USA, Inc. reported no revenue for the quarter ended June 30, 2026, with a substantial accumulated deficit and current liabilities far exceeding current assets, raising significant going concern issues.

Baltic International USA, Inc. reports a substantial accumulated deficit and working capital deficiency, with management expressing substantial doubt about its ability to continue as a going concern.